Skip to main content
. 2019 Sep 1;11(1):e2019048. doi: 10.4084/MJHID.2019.048

Table 2a.

Details on CMV management and reactivation for recipient of prophylactic Megalotect infusion (n=14).

Median dose of Megalotect (range) 50 UI/Kg (50–100)

Schedule
 Weekly 3 (21%)
 Every 2 weeks 5 (36%)
 Every 3 weeks 6 (43%)

Number of administration, median (range) 2 (1–9)

Subsequent CMV reactivation 0